Review Article
Volume 17 Issue 9 - 2021
Multisystem Inflammatory Syndrome in Children: An Overview
Suzanne Talal Kutbi*, Baraah Marwan Alsawaf, Thikra Abdullah Alzahrani, Hailah Hassan Alqarni, Ghadah Saeed Alzahrani, Aljowhara Salman Ali, Amwaj Jabir Mohanna and Shoaa Khalid Saeed Aldhahri
Aziziyah Children Hospital, Saudi Arabia
*Corresponding Author: Suzanne Talal Kutbi, Aziziyah Children Hospital, Saudi Arabia.
Received: July 23, 2021; Published: August 25, 2021




Abstract

Introduction: The first cases of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection was first seen in China in late 2019 and has rapidly spread across the world. As per the previous reports of SARS-CoV-2 infection, it was not seen very commonly in young children. The reason for such a low number of cases could be either asymptomatic cases or mild forms of the disease in this age group. A new syndrome termed "multisystem inflammatory syndrome in children" (MIS-C) was first described in April 2020, with a probable relation to SARS-CoV-2 infection.

Aim of Work: This review aims at highlighting an overview of, and an update on, the multisystem inflammatory syndrome in children.

Methodology: The review is a comprehensive research of WHO official page, Google Scholar, and PUBMED from the year 2005 to 2021.

Conclusion: A lot of knowledge has been gained about MIS-C temporally associated with COVID-19 in a very short span of time; nevertheless, there are still many uncertainties that exist. It is an unusual disease with varying severity and symptoms. The course of the disease is usually turbulent, leading to multiple organ failure and may require hospitalization in intensive care. Although an association does exist between SARS-CoV-2 and COVID-19, more serological tests and viral research need to be conducted to establish definitive evidence of COVID-19 being caused by SARS-CoV-2.

Keywords: Multisystem Inflammatory Syndrome in Children; Kawasaki Disease; Anticoagulants; Toxic Shock Syndrome; Immunoglobulins

References

  1. Nakra N A., et al. “Multi-system inflammatory syndrome in children (MIS-C) following SARS-CoV-2 infection: review of clinical presentation, hypothetical pathogenesis, and proposed management. Children 7.7 (2020): 69.
  2. World Health Organization. Responding to community spread of COVID-19: interim guidance, March 7 2020 (No. WHO/COVID-19/Community Transmission/2020.1). World Health Organization (2020).
  3. Blumfield E., et al. “Imaging findings in multisystem inflammatory syndrome in children (MIS-C) associated with coronavirus disease (COVID-19)”. American Journal of Roentgenology2 (2021): 507-517.
  4. Alunno A., et al. “Storm, typhoon, cyclone or hurricane in patients with COVID-19? Beware of the same storm that has a different origin”. RMD open1 (2020): e001295.
  5. Channappanavar R and Perlman S. “Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology”. In Seminars in immunopathology Springer Berlin Heidelberg5 (2017): 529-539.
  6. Law H K., et al. “Chemokine up-regulation in SARS-coronavirus–infected, monocyte-derived human dendritic cells”. Blood 7 (2005): 2366-2374.
  7. Kumar V. “Acute and chronic inflammation”. Pathologic Basis of Disease (2005): 47-86.
  8. Mehta P., et al. “COVID-19: consider cytokine storm syndromes and immunosuppression”. The Lancet10229 (2020): 1033-1034.
  9. Castagnoli R., et al. “Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in children and adolescents: a systematic review”. JAMA Pediatrics9 (2020): 882-889.
  10. Riphagen S., et al. “Hyperinflammatory shock in children during COVID-19 pandemic”. The Lancet10237 (2020): 1607-1608.
  11. Whittaker E., et al. “Clinical characteristics of 58 children with a pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2”. The Journal of the American Medical Association3 (2020): 259-269.
  12. Toubiana J., et al. “Kawasaki-like multisystem inflammatory syndrome in children during the covid-19 pandemic in Paris, France: prospective observational study”. British Medical Journal (2020): 369.
  13. Belhadjer Z., et al. “Acute heart failure in multisystem inflammatory syndrome in children in the context of global SARS-CoV-2 pandemic”. Circulation 5 (2020): 429-436.
  14. Simon H., et al. “Multisystem inflammatory syndrome associated with COVID-19 from the pediatric emergency physician's point of view☆”. Jornal de Pediatria 97 (2021): 140-159.
  15. McCrindle B W., et al. “Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association”. Circulation17 (2017): e927-e999.
  16. Chuang Y Y., et al. “Toxic shock syndrome in children”. Pediatric Drugs 1 (2005): 11-24.
  17. Henderson L A., et al. “On the alert for cytokine storm: immunopathology in COVID‐19”. Arthritis and Rheumatology 7 (2020): 1059-1063.
  18. Chesshyre E., et al. “Hemophagocytic lymphohistiocytosis and infections: An update”. The Pediatric Infectious Disease Journal3 (2019): e54-e56.
  19. McGonagle D., et al. “The role of cytokines including interleukin-6 in COVID-19 induced pneumonia and macrophage activation syndrome-like disease”. Autoimmunity Reviews6 (2020): 102537.
  20. Assessment RR. “Paediatric Inflammatory Multisystem Syndrome and SARS-CoV-2 Infection in Children (2020).
  21. Radia T., et al. “Multi-system inflammatory syndrome in children and adolescents (MIS-C): A systematic review of clinical features and presentation”. Paediatric Respiratory Reviews (2020).
  22. Cancio M., et al. “Emerging trends in COVID-19 treatment: learning from inflammatory conditions associated with cellular therapies”. Cytotherapy (2020).
  23. Wang Y., et al. “Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial”. The Lancet10236 (2020): 1569-1578.
  24. Beigel J H., et al. “Remdesivir for the treatment of Covid-19-preliminary report”. New England Journal of Medicine (2020).
  25. Tang N., et al. “Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy”. Journal of Thrombosis and Haemostasis5 (2020): 1094-1099.
Citation: Suzanne Talal Kutbi., et al. “Multisystem Inflammatory Syndrome in Children: An Overview” EC Microbiology 17.9 (2021): 01-08.

PubMed Indexed Article


EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005


EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777


EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347


EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478


EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253


EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033


EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992


EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505


EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793


EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211


EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047


EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560


EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318


EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819


EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840


EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344


EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476


EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658


EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489


EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278


EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108


EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571


EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333


EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883


EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001


EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937


EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723


EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726


EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603


EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646


EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616


EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290


EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226


EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812


EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268


News and Events


November Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the November issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for Upcoming Issue

ECronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before December 15, 2022.

Certificate of Publication

ECronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

ECronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.